Focal seizures were controlled with treatment in 60% of individuals with TSC1 compared with only 22.6% of those with TSC2. Infantile spasms were controlled with treatment in 28.3% of individuals with TSC2. This evidence concerns the gene TSC1 and infantile spasms.